WHO ICTRP trial
GrUVen-I Study
RPCEC00000106 · Registro Público Cubano de Ensayos Clínicos (RPCEC) · Not Recruiting
Key facts
| Trial ID | RPCEC00000106 |
|---|---|
| Public title | GrUVen-I Study |
| Scientific title | Human Recombinant Epidermal Growth Factor in patients with venous ulcers. |
| Primary sponsor | Center for Genetic Engineering and Biotechnology (CIGB), in Havana. |
| Secondary sponsors | Not applicable |
| Registry | Registro Público Cubano de Ensayos Clínicos (RPCEC) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 2 |
| Countries | Cuba |
| Conditions | Venous ulcers. |
| Interventions | The test product was administered topically to the lesion, 3 times a week (after the treatment with physiological saline) for 8 to 12 weeks, according to the randomization of patients. Group I: viscous solution of carboxymethylcellulose… |
| Registration date | Mar 5, 2011 |
| Target size | 50 |
| Secondary IDs | IG/FCU/UV/0401 |
| Registry page | rpcec.sld.cu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: